Ingevity Corporation (NYSE:NGVT) Accelerates Operational Reset, Poised For Near-Term Consolidation

Recent portfolio repositioning and a WMDST under-valued assessment set a constructive cash-flow backdrop, while elevated leverage and mixed margin signals argue for measured upside over the next weeks.

Recent News

Oct 23, 2025 — Ingevity announced dates for its third-quarter 2025 earnings release (to be published Nov 5, 2025) and an investor webcast Nov 6, 2025; Nov 6, 2025 — the company announced a virtual Strategic Portfolio Update slated for Dec 8, 2025 led by the CEO and CFO.

Technical Analysis

Directional indicators show a strong trend environment: ADX at 30.52 signals a strong trend and suggests continued directional conviction in the near term.

DI+ currently shows a peak-and-reversal, a bearish directional signal, while DI- sits lower and decreasing, which provides some offset to the DI+ reversal; together these readings indicate momentum pressure that could favor consolidation rather than a fresh directional thrust.

MACD sits at 1.76, above its signal line at 1.21 and trending higher, which denotes bullish momentum and a recent MACD crossover above the signal line—support for further positive price bias if momentum sustains.

MRO at 33.26 registers positive, indicating price currently sits above the modeled target and implying potential for a pullback from current levels despite momentum signals.

RSI at 55.24 and rising reflects moderate bullish momentum without overbought extremes, compatible with a measured advance rather than an extended rally.

Price structure favors the bulls on a moving-average basis: the close at $59.77 sits above the 20-day average ($56.92), 50-day average ($53.61) and 200-day average ($47.63), while the 12-day EMA trends up—consistent with recent upside but with the price close to the 1x upper Bollinger band ($60.13), which often precedes consolidation or a pause.

Volume has averaged below the 10-day mean on the latest session and 42-day volatility remains muted (0.03), indicating the current move lacks aggressive volume expansion and could revert to a holding pattern absent new catalysts.

 


Fundamental Analysis

Revenue and profitability: total revenue $365.1M with YoY revenue growth of 92.31% and a QoQ decline of roughly 6.77%, reflecting strong year-over-year momentum combined with recent quarter-level contraction.

EPS and cash flow: reported EPS $1.52 versus an estimate of $1.39, a beat of $0.13 or about 9.35%. Operating cash flow $79.0M and free cash flow $66.8M yield a free-cash-flow yield of 3.75%, which supports the cash-flow basis for valuation.

Margins present a split picture: gross margin at 37.77% sits roughly in line with the industry peer mean (37.69%), while operating margin at 23.53% stands above the industry peer mean (13.91%). By contrast, reported EBIT came in at $-122.7M, producing an EBIT margin of -33.61%, which falls below the industry peer low of -29.03%.

Balance sheet and leverage: total debt $1,375.5M with net debt $1,253.4M and cash $76.9M. Debt-to-equity at 11.396 (1,139.6%) and debt-to-assets 73.26% sit above the industry peer highs—these levels indicate materially higher leverage compared with peers.

Capital efficiency: asset turnover at 0.1856 sits slightly above the industry peer mean of 0.1594, suggesting relatively efficient revenue generation from assets despite the elevated leverage profile.

Valuation: WMDST values the stock as under-valued. Market multiples include a P/E of 31.12, forward P/E of 40.42 and a P/B of 14.76; the company’s price-target mean sits at $67.58, with a high/low analyst range from $109.44 to $33.24. Free-cash-flow generation and recent guidance figures form the primary support for WMDST’s under-valued assessment.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2025-06-30
REPORT DATE: 2025-11-05
NEXT REPORT DATE: 2026-02-04
CASH FLOW  Begin Period Cash Flow 90.9 M
 Operating Cash Flow 79.0 M
 Capital Expenditures -12.20 M
 Change In Working Capital -6.50 M
 Dividends Paid
 Cash Flow Delta 16.2 M
 End Period Cash Flow 107.1 M
 
INCOME STATEMENT REVENUE
 Total Revenue 365.1 M
 Forward Revenue -23.00 M
COSTS
 Cost Of Revenue 227.2 M
 Depreciation 25.6 M
 Depreciation and Amortization 25.6 M
 Research and Development 7.8 M
 Total Operating Expenses 279.2 M
PROFITABILITY
 Gross Profit 137.9 M
 EBITDA -97.10 M
 EBIT -122.70 M
 Operating Income 85.9 M
 Interest Income 1.1 M
 Interest Expense 20.0 M
 Net Interest Income -18.90 M
 Income Before Tax -142.70 M
 Tax Provision 3.8 M
 Tax Rate 21.0 %
 Net Income -146.50 M
 Net Income From Continuing Operations -146.50 M
EARNINGS
 EPS Estimate 1.39
 EPS Actual 1.52
 EPS Difference 0.13
 EPS Surprise 9.353 %
 Forward EPS 1.01
 
BALANCE SHEET ASSETS
 Total Assets 1.9 B
 Intangible Assets 283.4 M
 Net Tangible Assets -162.70 M
 Total Current Assets 536.0 M
 Cash and Short-Term Investments 76.9 M
 Cash 76.9 M
 Net Receivables 193.4 M
 Inventory 220.3 M
 Long-Term Investments 160.5 M
LIABILITIES
 Accounts Payable 101.5 M
 Short-Term Debt 94.7 M
 Total Current Liabilities 393.1 M
 Net Debt 1.3 B
 Total Debt 1.4 B
 Total Liabilities 1.8 B
EQUITY
 Total Equity 120.7 M
 Retained Earnings 446.0 M
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 3.31
 Shares Outstanding 36.465 M
 Revenue Per-Share 10.01
VALUATION
 Market Capitalization 1.8 B
 Enterprise Value 3.1 B
 Enterprise Multiple -31.717
Enterprise Multiple QoQ -183.359 %
Enterprise Multiple YoY 439.507 %
Enterprise Multiple IPRWA high: 85.583
median: 84.899
mean: 60.367
NGVT: -31.717
low: -118.916
 EV/R 8.435
CAPITAL STRUCTURE
 Asset To Equity 15.557
 Asset To Liability 1.069
 Debt To Capital 0.919
 Debt To Assets 0.733
Debt To Assets QoQ 4.444 %
Debt To Assets YoY 1518.895 %
Debt To Assets IPRWA NGVT: 0.733
high: 0.589
median: 0.378
mean: 0.336
low: 0.003
 Debt To Equity 11.396
Debt To Equity QoQ 85.39 %
Debt To Equity YoY 3051.031 %
Debt To Equity IPRWA NGVT: 11.396
high: 2.178
median: 0.962
mean: 0.767
low: 0.003
PRICE-BASED VALUATION
 Price To Book (P/B) 14.757
Price To Book QoQ 149.43 %
Price To Book YoY 151.763 %
Price To Book IPRWA NGVT: 14.757
high: 8.429
median: 6.71
mean: 5.127
low: 0.307
 Price To Earnings (P/E) 31.122
Price To Earnings QoQ -19.305 %
Price To Earnings YoY -31.57 %
Price To Earnings IPRWA high: 139.289
median: 139.289
mean: 103.681
NGVT: 31.122
low: -3.22
 PE/G Ratio 0.77
 Price To Sales (P/S) 4.878
Price To Sales QoQ -0.176 %
Price To Sales YoY 14.151 %
Price To Sales IPRWA high: 20.44
median: 19.039
mean: 12.995
NGVT: 4.878
low: 0.914
FORWARD MULTIPLES
Forward P/E 40.424
Forward PE/G 1.0
Forward P/S -77.429
EFFICIENCY OPERATIONAL
 Operating Leverage -12.529
ASSET & SALES
 Asset Turnover Ratio 0.186
Asset Turnover Ratio QoQ 33.29 %
Asset Turnover Ratio YoY 15.077 %
Asset Turnover Ratio IPRWA high: 0.334
NGVT: 0.186
median: 0.175
mean: 0.159
low: 0.003
 Receivables Turnover 2.045
Receivables Turnover Ratio QoQ 9.692 %
Receivables Turnover Ratio YoY 5.931 %
Receivables Turnover Ratio IPRWA high: 2.422
NGVT: 2.045
mean: 1.477
median: 1.361
low: 0.117
 Inventory Turnover 0.976
Inventory Turnover Ratio QoQ 35.036 %
Inventory Turnover Ratio YoY 14.487 %
Inventory Turnover Ratio IPRWA high: 2.465
median: 1.426
mean: 1.178
NGVT: 0.976
low: 0.034
 Days Sales Outstanding (DSO) 44.625
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 113.063
Cash Conversion Cycle Days QoQ 1.515 %
Cash Conversion Cycle Days YoY 2.522 %
Cash Conversion Cycle Days IPRWA high: 488.171
NGVT: 113.063
mean: 93.564
median: 55.266
low: -103.0
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 2.555
 CapEx To Revenue -0.033
 CapEx To Depreciation -0.477
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 1.4 B
 Net Invested Capital 1.5 B
 Invested Capital 1.5 B
 Net Tangible Assets -162.70 M
 Net Working Capital 142.9 M
LIQUIDITY
 Cash Ratio 0.196
 Current Ratio 1.364
Current Ratio QoQ -31.927 %
Current Ratio YoY -28.861 %
Current Ratio IPRWA high: 6.372
mean: 1.981
median: 1.53
NGVT: 1.364
low: 0.717
 Quick Ratio 0.803
Quick Ratio QoQ -25.334 %
Quick Ratio YoY -25.131 %
Quick Ratio IPRWA high: 3.851
mean: 1.338
median: 1.122
low: 0.825
NGVT: 0.803
COVERAGE & LEVERAGE
 Debt To EBITDA -14.166
 Cost Of Debt 1.122 %
 Interest Coverage Ratio -6.135
Interest Coverage Ratio QoQ -368.084 %
Interest Coverage Ratio YoY -52.382 %
Interest Coverage Ratio IPRWA high: 24.749
median: 9.66
mean: 7.601
NGVT: -6.135
low: -45.933
 Operating Cash Flow Ratio -0.337
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 56.109
DIVIDENDS
 Dividend Coverage Ratio
 Dividend Payout Ratio
 Dividend Rate
 Dividend Yield
PERFORMANCE GROWTH
 Asset Growth Rate -8.677 %
 Revenue Growth 28.556 %
Revenue Growth QoQ -676.539 %
Revenue Growth YoY 92.309 %
Revenue Growth IPRWA high: 47.859 %
NGVT: 28.556 %
median: 8.936 %
mean: 7.995 %
low: -4.472 %
 Earnings Growth 40.404 %
Earnings Growth QoQ 859.487 %
Earnings Growth YoY -57.122 %
Earnings Growth IPRWA high: 346.154 %
NGVT: 40.404 %
mean: 26.216 %
median: 26.0 %
low: -380.0 %
MARGINS
 Gross Margin 37.77 %
Gross Margin QoQ -5.409 %
Gross Margin YoY 19.749 %
Gross Margin IPRWA high: 62.406 %
median: 42.61 %
NGVT: 37.77 %
mean: 37.693 %
low: -24.576 %
 EBIT Margin -33.607 %
EBIT Margin QoQ -300.507 %
EBIT Margin YoY -57.723 %
EBIT Margin IPRWA high: 46.541 %
median: 18.287 %
mean: 15.501 %
low: -29.028 %
NGVT: -33.607 %
 Return On Sales (ROS) 23.528 %
Return On Sales QoQ 40.373 %
Return On Sales YoY -129.598 %
Return On Sales IPRWA NGVT: 23.528 %
high: 20.494 %
median: 18.253 %
mean: 13.908 %
low: -33.437 %
CASH FLOW
 Free Cash Flow (FCF) 66.8 M
 Free Cash Flow Yield 3.75 %
Free Cash Flow Yield QoQ 237.838 %
Free Cash Flow Yield YoY 439.568 %
Free Cash Flow Yield IPRWA high: 5.667 %
NGVT: 3.75 %
mean: 0.972 %
median: 0.633 %
low: -1.464 %
 Free Cash Growth 333.766 %
Free Cash Growth QoQ -646.164 %
Free Cash Growth YoY -337.695 %
Free Cash Growth IPRWA NGVT: 333.766 %
high: 268.897 %
median: 266.0 %
mean: 10.011 %
low: -926.923 %
 Free Cash To Net Income -0.456
 Cash Flow Margin -36.237 %
 Cash Flow To Earnings 0.903
VALUE & RETURNS
 Economic Value Added 0.03
 Return On Assets (ROA) -7.448 %
Return On Assets QoQ -841.095 %
Return On Assets YoY -36.429 %
Return On Assets IPRWA high: 11.068 %
median: 2.274 %
mean: 1.544 %
NGVT: -7.448 %
low: -15.06 %
 Return On Capital Employed (ROCE) -8.265 %
 Return On Equity (ROE) -1.214
Return On Equity QoQ -1489.048 %
Return On Equity YoY 21.845 %
Return On Equity IPRWA high: 0.233
median: 0.056
mean: 0.043
low: -0.154
NGVT: -1.214
 DuPont ROE -82.465 %
 Return On Invested Capital (ROIC) -6.68 %
Return On Invested Capital QoQ -398.614 %
Return On Invested Capital YoY -100.112 %
Return On Invested Capital IPRWA high: 4.864 %
median: 3.363 %
mean: 2.565 %
NGVT: -6.68 %
low: -11.907 %

Six-Week Outlook

Expect a consolidation regime with a mild bullish tilt. Momentum indicators (MACD crossover and rising RSI) favor additional upside attempts, while MRO’s positive reading warns the current price sits above modeled targets and increases the probability of a retracement. ADX confirms trend strength, but DI+ peak-and-reversal signals raise the risk that the trend will pause or pull back into the $55–$56 area (proximate to the super-trend lower at $55.09) before any meaningful follow-through. Liquidity and leverage metrics counsel monitoring company-level news (strategic-portfolio updates or operational announcements) as catalysts that could shift the balance of momentum over a multi-week horizon.

About Ingevity Corporation

Ingevity Corporation (NYSE:NGVT) manufactures and sells a diverse range of products through its three main segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers and produces hardwood-based and chemically activated carbon products, which serve critical roles in gasoline vapor emission control systems for vehicles and in purification applications for food, water, and chemicals. The Performance Chemicals segment develops products used in road construction and maintenance, including pavement preservation and recycling, as well as industrial specialties like agrochemical dispersants and paper chemicals. The Advanced Polymer Technologies segment focuses on producing caprolactone and caprolactone-based specialty polymers. These polymers find applications in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. Ingevity Corporation caters to a global market, including North America, Asia Pacific, Europe, the Middle East, Africa, and South America. Headquartered in North Charleston, South Carolina, Ingevity continues to serve automotive parts and components manufacturers through a network of sales representatives and distributors.



© 2025 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.